http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003039986-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4468fc75dcfd46910b4cd8618fcac652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd745ddb41c1eca5cc5801f59d6f827d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaefc7f7b38dc3b970199591c17c575f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b61f154ed12201d516dbb1e088ff95cb |
| publicationDate | 2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003039986-A1 |
| titleOfInvention | Compositions and methods relating to prostate specific genes and proteins |
| abstract | The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate tissue, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered prostate tissue for treatment and research. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012079016-A1 |
| priorityDate | 2000-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 3136.